Show simple item record

Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications

dc.contributor.authorHerman, William H.en_US
dc.contributor.authorAubert, R. E.en_US
dc.contributor.authorEngelgau, M. M.en_US
dc.contributor.authorThompson, Theodore J.en_US
dc.contributor.authorAli, M. A.en_US
dc.contributor.authorSous, E. S.en_US
dc.contributor.authorHegazy, M.en_US
dc.contributor.authorBadran, A.en_US
dc.contributor.authorKenny, S. J.en_US
dc.contributor.authorGunter, E. W.en_US
dc.contributor.authorMalarcher, A. M.en_US
dc.contributor.authorBrechner, R. J.en_US
dc.contributor.authorWetterhall, S. F.en_US
dc.contributor.authorDeStefano, F.en_US
dc.contributor.authorSmith, P. J.en_US
dc.contributor.authorHabib, M.en_US
dc.contributor.authorabd el Shakour, S.en_US
dc.contributor.authorIbrahim, A. S.en_US
dc.contributor.authorel Behairy, el Moneimen_US
dc.date.accessioned2006-04-19T13:59:46Z
dc.date.available2006-04-19T13:59:46Z
dc.date.issued1998-12en_US
dc.identifier.citationHerman, W.H.; Aubert, R.E.; Engelgau, M.M.; Thompson, T.J.; Ali, M.A.; Sous, E.S.; Hegazy, M.; Badran, A.; Kenny, S.J.; Gunter, E.W.; Malarcher, A.M.; Brechner, R.J.; Wetterhall, S.F.; DeStefano, F.; Smith, P.J.; Habib, M.; abd el Shakour, S.; Ibrahim, A.S.; el Behairy, el Moneim (1998)."Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications." Diabetic Medicine 15(12): 1045-1051. <http://hdl.handle.net/2027.42/34940>en_US
dc.identifier.issn0742-3071en_US
dc.identifier.issn1096-9136en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/34940
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9868980&dopt=citationen_US
dc.description.abstractWe performed a cross-sectional, population-based survey of persons 20 years of age and older living in Cairo and surrounding rural villages. The purpose was to describe glycaemic control and the prevalence of microvascular and neuropathic complications among Egyptians with diagnosed diabetes, previously undiagnosed diabetes, impaired glucose tolerance, and normal glucose tolerance. A total of 6052 households were surveyed. The response rate was 76 % for the household survey and 72 % for the medical examination. Among people with previously diagnosed diabetes, mean haemoglobin A 1c was 9.0 %. Forty-two per cent had retinopathy, 21 % albuminuria, and 22 % neuropathy. Legal blindness was prevalent (5 %) but clinical nephropathy (7 %) and foot ulcers (1 %) were uncommon in persons with diagnosed diabetes. Among people with diagnosed diabetes, microvascular and neuropathic complications were associated with hyperglycaemia. Retinopathy was also associated with duration of diabetes; albuminuria with hypertension and hypercholesterolaemia; and neuropathy with age, female sex, and hypercholesterolaemia. Albuminuria was as common in people with previously undiagnosed diabetes (22 %) as those with diagnosed disease (21 %). Mean haemoglobin A 1c was lower (7.8 %) and retinopathy (16 %) and neuropathy (14 %) were less prevalent in people with previously undiagnosed disease. Ocular conditions, blindness, and neuropathy were prevalent in the non-diabetic population. The microvascular and neuropathic complications of diabetes are a major clinical and public health problem in Egypt. Copyright © 1998 John Wiley & Sons, Ltd.en_US
dc.format.extent85784 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherJohn Wiley & Sons, Ltd.en_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherDiabetes and Clinical Endocrinologyen_US
dc.titleDiabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complicationsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Ann Arbor, Michigan, USA ; University of Michigan Medical Center, 1500 E. Medical Center Drive, 3920 Taubman Center, Box 0354 Ann Arbor, MI 48109-0354, USAen_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherDiabetes Institute, Ministry of Health, Cairo, Egypten_US
dc.contributor.affiliationotherDiabetes Institute, Ministry of Health, Cairo, Egypten_US
dc.contributor.affiliationotherDiabetes Institute, Ministry of Health, Cairo, Egypten_US
dc.contributor.affiliationotherDiabetes Institute, Ministry of Health, Cairo, Egypten_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherEnvironmental Health Laboratory, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherEpidemiology and Statistics Branch, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USAen_US
dc.contributor.affiliationotherDiabetes Institute, Ministry of Health, Cairo, Egypten_US
dc.contributor.affiliationotherDiabetes Institute, Ministry of Health, Cairo, Egypten_US
dc.contributor.affiliationotherDiabetes Institute, Ministry of Health, Cairo, Egypten_US
dc.contributor.affiliationotherCentral Health Laboratories, Ministry of Health, Cairo, Egypten_US
dc.identifier.pmid9868980en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/34940/1/696_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-Len_US
dc.identifier.sourceDiabetic Medicineen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.